Jan 19, 2023 | Lung Cancer
1b) Our expert author is Nicolas Girard @nicogirardcurie, #lungcancer & rare #thoracic #tumors specialist from Institut Curie, Paris @institut_curie. 🇫🇷 Follow us on @onc_ce for the latest updates in #oncology and 🆓CE/#CME! Prior programs for credit at...
Jan 16, 2023 | Lung Cancer
1b) Our expert authors are @NarjustFlorezMD, Assoc. Director CCEP & Thoracic Oncology @DanaFarberNews and her mentee @ShrutiPatelMD, #MedOnc fellow @StanfordCancer. Earn 🆓CE/CME credit for following this 🧵! pic.twitter.com/Kvz0rtScuB— @onc_ce (@onc_ce)...
Jan 9, 2023 | Lung Cancer
2) I am Dr. Sandip Patel @PatelOncology, Professor in Medical Oncology from @UCSDCancer. @nicogirardcurie (to follow) and I will be covering Optimal Immuno-Oncologic Management of Extensive-Stage Small Cell Lung Cancer & Strategies to Develop Individualized...
Dec 15, 2022 | Lung Cancer
2) I am Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare @HemOncFellows @Oncoalert and now we are covering @myESMO #ESMOImmuno22 updates/review on “Biomarker Targeted Therapies” in #LCSM! pic.twitter.com/sJb9PPWYFH— @onc_ce (@onc_ce) December 15,...
Oct 15, 2022 | Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #ADCs in development for #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹— @onc_ce (@onc_ce) October 18, 2022 3b) This content is intended for healthcare...
Sep 26, 2022 | Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #HER2 mutant #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹 pic.twitter.com/URaLLizjRH— @onc_ce (@onc_ce) September 27, 2022 3b) This content is...